Lyad Gozal
Psychiatry · West Palm Beach, FLNPI 1386760346
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 573 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,939, more than ten times the $290 reported in 2019. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 573 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$999
- Teva Pharmaceuticals USA, Inc.$979
- plus $3K from 17 others
What the payments were for
- Food & beverage$9,85299%
- Education$1051%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 110 | $1,763 |
| Otsuka America Pharmaceutical, Inc. | 65 | $1,296 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 70 | $1,107 |
| Johnson & Johnson | 51 | $1,007 |
| Neurocrine Biosciences, Inc. | 48 | $999 |
| Teva Pharmaceuticals USA, Inc. | 64 | $979 |
| Alkermes, Inc. | 58 | $899 |
| Lundbeck LLC | 18 | $313 |
| Vanda Pharmaceuticals Inc. | 14 | $293 |
| Supernus Pharmaceuticals, Inc. | 18 | $275 |
| E.r. Squibb & Sons, L.L.C. | 14 | $251 |
| Indivior Inc. | 9 | $198 |
| Tris Pharma Inc | 5 | $93 |
| Collegium Pharmaceutical, Inc. | 5 | $78 |
| Ironshore Pharmaceuticals Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $70 |
| Noven Therapeutics, LLC | 3 | $58 |
| Sunovion Pharmaceuticals Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Adlon Therapeutics L.p. | 3 | $41 |
| Shire North American Group Inc | 2 | $34 |
| Corium, LLC | 2 | $26 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
How this compares
$9,957 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 14 | $4,269 |
| Trazodone Hcl | 137 | $3,365 |
| Aripiprazole | 77 | $1,731 |
| Olanzapine | 28 | $1,222 |
| Atomoxetine Hcl | 11 | $1,120 |
| Haloperidol | 37 | $967 |
| Fluphenazine Hcl | 11 | $784 |
| Gabapentin | 81 | $536 |
| Buspirone Hcl | 70 | $522 |
| Oxcarbazepine | 19 | $450 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $379 |
| Quetiapine Fumarate | 45 | $364 |
| Topiramate | 32 | $333 |
| Citalopram HbrCitalopram Hydrobromide | 19 | $308 |
| Hydroxyzine Pamoate | 16 | $285 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in West Palm Beach
- Mouville Caro-GraciaWest Palm Beach$69K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.